21 CFR § 524.1132 Ophthalmic and Topical Dosage Form New Animal Drugs

§ 524.1132 Hydrocortisone, miconazole, and gentamicin otic suspension.

Current through Sep 8, 2026 · Read all of Part 524

(a) Specifications. Each milliliter (mL) of suspension contains 1.11 milligrams (mg) hydrocortisone aceponate, 17.4 mg miconazole nitrate, and 1.5 mg gentamicin (as gentamicin sulfate).

(b) Sponsor. See No.051311 in § 510.600(c) of this chapter.

(c) Conditions of use in dogs—(1) Amount. Instill 1.0 mL in the affected ear once daily for 5 days.

(2) Indications for use. For the treatment of otitis externa in dogs associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius).

(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

[76 FR 78150, Dec. 16, 2011, as amended at 83 FR 13635, Mar. 30, 2018]

← § 524.1044i Gentamicin and betamethasone ophthalmic solution.§ 524.1140 Imidacloprid and ivermectin. →